A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults

Patricia Winokur, Theresa E Hegmann, Hana M El Sahly, Evan J Anderson, Unknown, Nancy Wagner, Tom Kaufman, Wendy A Keitel, Robert L Atmar, Jumi Yi, Inci Yildirim, Carol Kao, Etza Peters, Kathy Stephens, Christina Rostad, Walla Dempsey, Venus Shahamatdar, Tatiana Beresney, Kay Tomashek

Open source

DOI: 10.1093/infdis/jiaf571
Published: 2025-11-28
Container: The Journal of Infectious Diseases
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiaf571,
  title = {A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults},
  author = {Patricia Winokur and Theresa E Hegmann and Hana M El Sahly and Evan J Anderson and Unknown and Nancy Wagner and Tom Kaufman and Wendy A Keitel and Robert L Atmar and Jumi Yi and Inci Yildirim and Carol Kao and Etza Peters and Kathy Stephens and Christina Rostad and Walla Dempsey and Venus Shahamatdar and Tatiana Beresney and Kay Tomashek},
  year = {2025},
  journal = {The Journal of Infectious Diseases},
  doi = {10.1093/infdis/jiaf571},
  url = {https://doi.org/10.1093/infdis/jiaf571}
}

RIS

TY  - JOUR
TI  - A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults
AU  - Patricia Winokur
AU  - Theresa E Hegmann
AU  - Hana M El Sahly
AU  - Evan J Anderson
AU  - Unknown
AU  - Nancy Wagner
AU  - Tom Kaufman
AU  - Wendy A Keitel
AU  - Robert L Atmar
AU  - Jumi Yi
AU  - Inci Yildirim
AU  - Carol Kao
AU  - Etza Peters
AU  - Kathy Stephens
AU  - Christina Rostad
AU  - Walla Dempsey
AU  - Venus Shahamatdar
AU  - Tatiana Beresney
AU  - Kay Tomashek
PY  - 2025
JO  - The Journal of Infectious Diseases
DO  - 10.1093/infdis/jiaf571
UR  - https://doi.org/10.1093/infdis/jiaf571
ER  -

APA

Winokur, P., Hegmann, T. E., Sahly, H. M. E., Anderson, E. J., Unknown, Wagner, N., Kaufman, T., Keitel, W. A., Atmar, R. L., Yi, J., Yildirim, I., Kao, C., Peters, E., Stephens, K., Rostad, C., Dempsey, W., Shahamatdar, V., Beresney, T., & Tomashek, K. (2025). A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf571

Source records

crossref · retrieved 2026-09-27T13:09:04.514Z